The Motley Fool··Jonathan PoncianoTarsus Pharma Rallies 20% Despite CHRO's $839K Share Sale
Tarsus Pharma stock surges 20% as insider sells shares for tax withholding. Strong XDEMVY sales growth and improving margins offset insider transaction.
TARSpipeline expansioninsider sale